Cell News and Research

RSS

New prototype technique improves diagnosis of cancer tissue during operation

Tissue-conserving cancer surgery is a highly skilled procedure which involves time-consuming tissue preparation to detect the margins of cancerous tissue. The goal is to remove as much of the tumour as possible while sparing healthy tissue.

18 Sep 2013

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

A preclinical study led by researchers at Children's National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy.

18 Sep 2013

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's volasertib

Boehringer Ingelheim Pharmaceuticals, Inc. today announced the FDA has granted Breakthrough Therapy designation to volasertib, an investigational inhibitor of polo-like kinase, being evaluated for the treatment of patients aged 65 or older with previously untreated acute myeloid leukemia, ineligible for intensive remission induction therapy.

17 Sep 2013

MR Solutions to release MR/PET and MR/SPECT scanners at WMIC

UK based MR Solutions continues to lead the technology revolution in pre clinical scanning with the launch of the first combined cryogen free, 3T, MR/PET and the first 3T, MR/SPECT scanners at the World Molecular Imaging Conference in Savannah this week (Sept 18-21st).

From MR Solutions 17 Sep 2013

UCSF neuroscientist wins Barancik Prize for multiple sclerosis research

Neuroscientist Jonah Chan, PhD, at the University of California, San Francisco, is the first recipient of a new international prize launched to recognize innovation and progress in multiple sclerosis research.

17 Sep 2013

Functional brain mapping and high speed physiology multiphoton system from Olympus

The Olympus FluoView® FVMPE-RS, a dedicated multiphoton microscope system, enables high-precision, ultra-fast scanning and stimulation, allowing researchers to see deep within specimens, take measurements at the highest speeds, and capture images even when working under the most demanding conditions.

From Evident Corporation - Life Sciences 17 Sep 2013

Improve Your Lifestyle, Lengthen Your Telomeres

...

17 Sep 2013

Inside Jersey magazine names Rutgers Cancer Institute of New Jersey physicians among Top Doctors

Several physicians at Rutgers Cancer Institute of New Jersey have been named as a 'Top Doctor' by Inside Jersey magazine.

17 Sep 2013

Video demonstrates high throughput screening of cellular bioenergetics of multiple cell lines

INTEGRA has published a video demonstrating how its VIAFLO 96 handheld electronic pipette, used in conjunction with the Seahorse Bioscience XF96 Extracellular Flux Analyzer, provides high throughput screening of the cellular bioenergetics of multiple cell lines.

From INTEGRA Biosciences 17 Sep 2013

Researchers discover how Yersinia immobilizes immune system to spread within organs

Researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have identified how one type of bacteria, Yersinia, immobilizes the immune system in order to grow in the organs of mice. To do so, the researchers extended the use of a technique and suggest that it could be used to study other bacteria that use the same or similar means of infection.

17 Sep 2013

New method to target, eliminate cancer-supporting macrophages in mouse tumors

When a person has cancer, some of the cells in his or her body have changed and are growing uncontrollably. Most cancer drugs try to treat the disease by killing those fast-growing cells, but another approach called immunotherapy tries to stimulate a person's own immune system to attack the cancer itself.

17 Sep 2013

Immune marker predicts transplant success, improves selection of bone marrow donors

The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.

17 Sep 2013

arGEN-X announces CTA filing of Phase Ib cancer study with ARGX-111

arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces today the CTA filing of a first-in-man Phase Ib cancer study with ARGX-111, its second proprietary SIMPLE Antibody product to enter the clinic this year.

17 Sep 2013

Research finding offers new approach to treating melanoma

Scientists at Sanford-Burnham Medical Research Institute today announced the discovery that a gene encoding an enzyme, phosphoinositide-dependent kinase-1, plays an essential role in the development and progression of melanoma. The finding offers a new approach to treating this life-threatening disease.

17 Sep 2013

Oil spill exposure appears to play role in development of hematologic and hepatic toxicity

A new study reports that workers exposed to crude oil and dispersants used during the Gulf oil spill cleanup display significantly altered blood profiles, liver enzymes, and somatic symptoms compared to an unexposed control group.

17 Sep 2013

NIEHS grant renewal opens next chapter in 18-year research effort into brain injury biomarker

The National Institute of Environmental Health Sciences (NIEHS) has awarded a five-year, $1.5 million grant extension to Columbia University's Mailman School of Public Health to fund research into the function of a biomarker for brain injury called Translocator Protein 18 kDa, better known as TSPO, in order to better understand its function in brain injury and inflammation and discover targets for therapy.

17 Sep 2013

TSRI scientists find new way to boost effectiveness of anticancer drugs

Scientists at The Scripps Research Institute (TSRI) have found a way to make dramatic improvements to the cancer cell-killing power of vinblastine, one of the most successful chemotherapy drugs of the past few decades.

17 Sep 2013

Kessler Foundation researcher honored for excellence in physical medicine and rehabilitation

Mooyeon Oh-Park, M.D., of Kessler Foundation was named 2013 "Teacher of the Year" in the Department of Physical Medicine and Rehabilitation at Rutgers New Jersey Medical School. This award is given each year to a faculty member who demonstrated outstanding knowledge in physical medicine and rehabilitation as well as dedication and skills in teaching.

17 Sep 2013

Study reports identification of IDH1 protein as novel biomarker for diagnosis of NSCLC

A protein called isocitrate dehydrogenase is present at high levels in lung cancers and can be detected in the blood, making it a noninvasive diagnostic marker for lung cancers, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

17 Sep 2013

microRNA-486 found to be potent tumor-suppressor molecule in lung cancer

New research shows that microRNA-486 is a potent tumor-suppressor molecule in lung cancer, and that the it helps regulate the proliferation and migration of lung-cancer cells, and the induction of programmed cell death, or apoptosis, in those cells.

17 Sep 2013

Cell News and Research

New prototype technique improves diagnosis of cancer tissue during operation

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's volasertib

MR Solutions to release MR/PET and MR/SPECT scanners at WMIC

UCSF neuroscientist wins Barancik Prize for multiple sclerosis research

Functional brain mapping and high speed physiology multiphoton system from Olympus

Improve Your Lifestyle, Lengthen Your Telomeres

Inside Jersey magazine names Rutgers Cancer Institute of New Jersey physicians among Top Doctors

Video demonstrates high throughput screening of cellular bioenergetics of multiple cell lines

Researchers discover how Yersinia immobilizes immune system to spread within organs

New method to target, eliminate cancer-supporting macrophages in mouse tumors

Immune marker predicts transplant success, improves selection of bone marrow donors

arGEN-X announces CTA filing of Phase Ib cancer study with ARGX-111

Research finding offers new approach to treating melanoma

Oil spill exposure appears to play role in development of hematologic and hepatic toxicity

NIEHS grant renewal opens next chapter in 18-year research effort into brain injury biomarker

TSRI scientists find new way to boost effectiveness of anticancer drugs

Kessler Foundation researcher honored for excellence in physical medicine and rehabilitation

Study reports identification of IDH1 protein as novel biomarker for diagnosis of NSCLC

microRNA-486 found to be potent tumor-suppressor molecule in lung cancer

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News